Medicine catalogue sources
Medicine identity and regulatory fields are based on governed catalogue records and Rwanda FDA source material. A regulatory listing supports product identity; it does not prove live pharmacy stock. Visit the Rwanda Food and Drugs Authority for the authority’s current public information.
Editorial and product-content policy
MED+250 preserves the official source title and applies restrained display cleanup for readability. Product descriptions are public only when their source rights, approval, and accountable review are recorded. Missing facts are left blank rather than inferred from a product name.
Prices and availability
Indicative prices are labelled as estimates and are not offers. Availability and final prices require a recent pharmacy confirmation. Structured offer data is withheld unless a current, positive, pharmacy-backed verification record passes the publication gate.
Clinical and prescription boundaries
Catalogue information is not medical advice. Prescription medicines require the applicable prescription and professional dispensing controls. For urgent or severe symptoms, contact qualified emergency or clinical services rather than relying on a marketplace search.
Localisation and local coverage
English is the currently approved public source language. Kinyarwanda remains blocked until qualified translation, glossary, clinical, and legal review evidence is complete. District or pharmacy-area pages are not published without verified operational coverage and partner consent.
Corrections
If a product detail, source, or marketplace statement appears wrong, use the public contact route and include the page address and the field to review. MED+250 can investigate the governed source record without treating a user report as an automatic catalogue change.
Contact MED+250Policy reviewed 27 August 2026. About MED+250